|
[1]
|
Yilmaz C, Ozcengiz G.Antibiotics: Pharmacokinetics, toxicity, resistance and multidrug efflux pumps[J].Biochem Pharmacol, 2017,133:43-62. |
|
[2]
|
De Wilde M, Speeckaert M, Callens R, et al.Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of "chronic Lyme disease"[J].Acta Clin Belg, 2017,72(2):133-137. |
|
[3]
|
Hanai Y, Matsuo K, Ogawa M, et al.A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia[J].J Infect Chemother, 2016,22(8):536-542. |
|
[4]
|
Wong RS, Cheng G, Chan NP, et al.Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency[J].Am J Hematol, 2006,81(1):76. |
|
[5]
|
Garratty G.Immune hemolytic anemia caused by drugs[J].Expert Opin Drug Saf, 2012,11(4):635-642. |
|
[6]
|
Macy E.Penicillin and beta-lactam allergy: epidemiology and diagnosis[J].Curr Allergy Asthma Rep, 2014,14(11):476. |
|
[7]
|
张 兵, 冯变玲, 赵晓红, 等.青霉素类药物不良反应报告分析[J].西北药学杂志, 2013,28(5):524-526. |
|
[8]
|
张小林.β-内酰胺类抗生素对血液系统的影响[J].国际输血及血液学杂志, 1997,20(2):68-71. |
|
[9]
|
Ruiz-Irastorza G, Barreiro G,Aguirre C.Reversible bone marrow depression by high-dose piperacillin/tazobactam[J].Br J Haematol, 1996,95(4):611-612. |
|
[10]
|
李楚倩, 周陈西, 刘孟娟, 等.第3代头孢菌素致血液系统不良反应文献分析[J].中国药业, 2012,21(24):98-100. |
|
[11]
|
Shearer MJ, Bechtold H, Andrassy K, et al.Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status[J].J Clin Pharmacol, 1988,28(1):88-95. |
|
[12]
|
Neuman G, Boodhan S, Wurman I, et al.Ceftriaxone-induced immune hemolytic anemia[J].Ann Pharmacother, 2014,48(12):1594-1604. |
|
[13]
|
刘代红.药物诱发的免疫性溶血性贫血[J].中国实用内科杂志, 2012,32(5):338-339. |
|
[14]
|
Garratty G.Drug-induced immune hemolytic anemia[J].Clin Adv Hematol Oncol, 2010,8(2): 98-101. |
|
[15]
|
Kim S, Song KS, Kim HO, et al.Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine[J].Yonsei Med J, 2002, 43(3):391-394. |
|
[16]
|
Robinson HE, Maxwell EL, Prince HM, et al.Cefotetan-induced life-threatening haemolysis[J].Med J Aust, 2006,184(5):251. |
|
[17]
|
云 璐, 王 帅, 李 杰.注射用拉氧头孢钠引起凝血障碍1例[J].中国现代应用药学, 2012,29(9):860-860. |
|
[18]
|
Cazzola M, Brancaccio V, De Giglio C, et al.Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects[J].Int J Clin Pharmacol Ther Toxicol, 1993,31(3):148-152. |
|
[19]
|
吴 昕.临床应用氯霉素的不良反应[J].临床合理用药杂志, 2008,1(1):36-37. |
|
[20]
|
Turton JA, Andrews CM, Havard AC, et al.Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat[J].Food Chem Toxicol, 2002,40(12):1849-1861. |
|
[21]
|
马 勤, 黄滔敏.眼用制剂致不良反应208例文献分析[J].中国药房, 2013,24(44):4192-4195. |
|
[22]
|
孙元玲.氯霉素滴眼液致再生障碍性贫血1例[J].中国药事, 2000,14(2):136. |
|
[23]
|
Leiter LM, Thatte HS, Okafor C, et al.Chloramphenicol-induced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions[J].J Cell Physiol, 1999,180(3): 334-344. |
|
[24]
|
Harthan AA,Heger ML.Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency[J].J Pediatr Pharmacol Ther, 2013,18(2): 137-141. |
|
[25]
|
王 静, 赵 睿, 李明芬.复方新诺明的少见不良反应[J].中国药业, 2006,15(3): 77-78. |
|
[26]
|
张爱芬, 郝敬旺, 项林海.磺胺类药物不良反应及应对措施分析[J].临床医学研究与实践, 2016,1(20): 20-21. |
|
[27]
|
Gorchynski J, Rose JK.Complications of MRSA treatment: linezolid-induced myelosuppression presenting with pancytopenia[J].West J Emerg Med, 2008,9(3):177-178. |
|
[28]
|
Bernstein WB, Trotta RF, Rector JT, et al.Mechanisms for linezolid-induced anemia and thrombocytopenia[J].Ann Pharmacother, 2003,37(4):517-520. |
|
[29]
|
Dawson MA, Davis A, Elliott P, et al.Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited[J].Intern Med J, 2005,35(10):626-628. |
点击查看大图
下载:
